Skip to main content

Table 1 Super-biclusters in gastric cancer dataset

From: A bi-ordering approach to linking gene expression with clinical annotations in gastric cancer

  #Converging   P-values   Most significant biological process
SBC SBC Prototype MCS Malignancy Score GO  
SBC1 11 6 9.4 × 10-4 1.8 × 10-13 5.1 × 10-9 epidermis development
SBC2 188 7 1.0 × 10-8   7.1 × 10-7 lipid metabolic process
SBC3 2 1 1.5 × 10-6 5.5 × 10-8 3.2 × 10-32 immune system process
SBC4 96 2 1.8 × 10-1   2.0 × 10-53 immune system process
SBC5 15 15 1.1 × 10-18 7.7 × 10-21 1.8 × 10-14 cell cycle process
SBC6 328 11 3.0 × 10-7 4.9 × 10-8 1.8 × 10-20 multicellular organismal process
SBC7 359 229 4.0 × 10-14 -5.4 × 10-22 3.2 × 10-22 gen. of precursor metabolic & energy
SBC8 1 1 3.0 × 10-10 -5.2 × 10-8 2.2 × 10-2 lipid metabolic process
  1. Numerical characterisations and biological relevance of the eight super-biclusters generated by BOA on the gastric cancer data. In the second column of the table, the numbers of biclusters that converged to a particular super-bicluster are given, while the third column is the number of identical biclusters converging to the prototype of that super-bicluster. The columns of "MCS", "Malignancy Score" and "GO" contain the p-values calculated with respect to the prototype of each super-bicluster in terms of the three statistics described in Section 2.3. Note that the negative sign, '-', in the Malignancy Score for SBC7 and SBC8 indicates the significance of agreement with the reverse order.